Thymosin Alpha-1
Your immune system's master trainer—a naturally occurring thymus peptide that wakes up tired immune cells, helps your body fight infections, and keeps your defenses sharp as you age.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
1.6 mg
Compound profile
Thymosin Alpha-1 scientific & efficacy data
Immune
Peptide profile
Moderate human trials
Thymosin Alpha-1
1.6 mg · Twice weekly
Molecular formula
C129H215N33O55
- Mol. weight
- 3108.32 g/mol
- CAS number
- 62304-98-7
- PubChem
- 16130571
- Developed · 1972
- Allan L. Goldstein, PhD
University of Texas Medical Branch / George Washington University
Amino acid sequence
Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn (Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN)Immune Activation
Directly enhances T-cell and dendritic cell function with extensive clinical validation across thousands of patients
Infection Fighting
In chronic hepatitis B, HBV DNA cleared in 40.6% at 6 months against 9.4% of untreated controls in one randomized trial, though results across trials were mixed. [4] With interferon in hepatitis C, HCV RNA cleared in 65% against 29% on interferon alone. [4]
Immune Balance
Unique ability to boost immunity while preventing harmful overreaction through IDO pathway activation
Dosing
How much Thymosin Alpha-1 do I take?
1.6 mg
1.6 mg
Covers all 2 documented dose levels · timing · dose-adjustment guidance.
Every documented dose level
| Phase | Dose | Frequency |
|---|---|---|
| 6-12 months | 1.6 mg | Twice weekly (3-4 days apart) |
| 12+ weeks | 1.6 mg daily, then 1.6 mg twice weekly | Daily for an initial loading period, then twice weekly |
Suitability
Is Thymosin Alpha-1 right for me?
Best for immune system strengthening & chronic infection support
Best for
Chronic Hepatitis B or C Support
Thymosin Alpha-1 has its strongest clinical evidence here. Multiple trials show it helps clear viral loads and normalize liver enzymes, especially when combined with antiviral medications. It's approved in over 30 countries specifically for hepatitis treatment.
Cancer Treatment Support
When used alongside chemotherapy, Thymosin Alpha-1 may help maintain immune function that chemo tends to suppress. Research in lung cancer, melanoma, and liver cancer shows improved outcomes when added to standard treatments. It helps your immune system keep fighting even during tough treatments.
Age-Related Immune Decline
As you age, your thymus shrinks and produces less thymosin naturally—a process called immunosenescence. Supplementing with Thymosin Alpha-1 may help compensate, keeping your immune defenses more youthful and responsive. Think of it as replacing what your body makes less of over time.
Severe Infection Recovery
In sepsis and critical infections, Thymosin Alpha-1 has shown promise for reducing mortality by helping restore immune balance. It's particularly interesting because it modulates immunity rather than just boosting it—calming overreaction while enhancing pathogen-fighting ability.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Thymosin Alpha-1 with similar peptides to find the best fit for your goals.
Administration
How do I use Thymosin Alpha-1?
Subcutaneous injection
Route
Subcutaneous injection (just under the skin)—this is how it was used in all major clinical trials and provides reliable absorption
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is Thymosin Alpha-1 safe?
1 common side effect · 1 serious
Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries.
Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life means it doesn't accumulate in your system. It's been used safely in thousands of patients with hepatitis, cancer, and other serious conditions.
Safety data come from clinical trials in hepatitis B and C, cancer and critical illness. Most studies observed only local irritation at the injection site.
[4] In a 120-patient randomized trial in HBV-related acute-on-chronic liver failure, 1.6 mg was safe and improved 90-day transplant-free survival (75.0% vs 53.4%). [3] Thymalfasin is not FDA approved; it is used outside the US as Zadaxin. [6]
Less common
These typically resolve with continued use or dose adjustment.
Common side effects · experienced by some users
Injection site reactions
Redness, mild swelling, or discomfort where you injected is the most frequently reported effect. It's your skin's normal response to the injection process.
Management: Rotate injection sites with each dose. Ice the area briefly if uncomfortable. These reactions typically resolve within 24-48 hours.
Stop and seek help if
- Any signs of allergic reaction—stop immediately and seek medical help
- Worsening of any autoimmune symptoms you may have
- Persistent fever above 101°F that doesn't resolve
- Severe or spreading injection site reactions
- Any new symptoms that concern you or feel abnormal
- Completion of your prescribed treatment cycle
Thymosin Alpha-1 is approved for specific uses in some countries but remains a research compound for other applications. Always work with a qualified healthcare provider when using any peptide therapy. This information is educational—not medical advice for your specific situation.
With other peptides
- Safe:Thymalin — Excellent pairing—both support thymus function through complementary mechanisms. Often used together in immune protocols.
- Safe:BPC-157 — Safe combination. BPC-157 focuses on healing while Thymosin Alpha-1 handles immune function—different targets, no conflict.
- Safe:Epithalon — Can be combined for comprehensive aging support. Epithalon targets telomeres while Thymosin Alpha-1 supports immune aging.
- Safe:Thymosin Beta-4 — Same family, different functions. TB-500 is for tissue repair; TA-1 is for immune function. Can be used together safely.
With medications
- Caution:Immunosuppressants (cyclosporine, tacrolimus) — CONTRAINDICATED. Thymosin Alpha-1 stimulates immune function, directly opposing these medications. Could trigger transplant rejection.
- Caution:Corticosteroids (prednisone) — May reduce Thymosin Alpha-1 effectiveness. If you need steroids, timing separation may help. Discuss with your doctor.
- Safe:Interferon-alpha — Actually studied together extensively for hepatitis. The combination shows enhanced effectiveness in clinical trials.
- Safe:Chemotherapy drugs — Research supports using Thymosin Alpha-1 alongside chemo to maintain immune function. Should be coordinated with oncologist.
With supplements
- Safe:Vitamin D — Excellent combination. Vitamin D also supports immune function and may enhance Thymosin Alpha-1 effects.
- Safe:Zinc — Safe and complementary. Zinc is essential for immune function and supports T-cell development.
- Safe:Glutathione — Good pairing for overall immune and antioxidant support. No known interactions.
- Safe:Echinacea — Both stimulate immunity. While likely safe, watch for signs of overstimulation if using together long-term.
Effectiveness
How do I know Thymosin Alpha-1 is working?
Moderate human trials · first signs week 1-2
Evidence level
Moderate human trials
(Phase 1-2)
Regulatory status
Not FDA approved
There is no thymalfasin application in Drugs@FDA. It is used outside the US (as Zadaxin) for chronic hepatitis B and as an immune adjuvant.
Onset of effects
Moderate
(1-2 weeks)
How it works
Think of your thymus as a training camp for immune cells.
When you're young, it's busy churning out trained T-cells ready to fight infections and cancer. But as you age, your thymus shrinks and produces less of its natural trainer—thymosin.
Thymosin Alpha-1 is like bringing in a coach to keep training your immune cells even when your thymus has slowed down.
It teaches immature immune cells how to become effective fighters, helps experienced cells work better, and even keeps your immune system from overreacting to things it shouldn't attack.
The deeper mechanism
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide that acts as an immunomodulator through multiple converging pathways. It signals through Toll-like receptors (TLR2, TLR9) on dendritic cells and other antigen-presenting cells, promoting their maturation and antigen-presenting capacity.
This enhances T-cell priming and differentiation, particularly favoring Th1 responses. Tα1 increases T-cell precursor maturation markers including terminal deoxynucleotidyl transferase (TdT) expression in pre-T cells.
It upregulates IL-2 receptor expression on T-cells and enhances IL-2, IFN-α, and IFN-γ production while modulating IL-10 and other regulatory cytokines.
Uniquely, Tα1 activates indoleamine 2,3-dioxygenase (IDO) in dendritic cells, which provides negative feedback preventing excessive inflammation and autoimmunity—explaining its dual immune-boosting and immunomodulating properties.
The peptide also demonstrates direct effects on natural killer (NK) cell activity and may influence tumor cell apoptosis pathways. Its rapid absorption (Tmax ~2 hours) and short half-life (~2 hours) necessitate twice-weekly dosing for sustained immune effects.
What to expect
Week 1-2
What you might notice
- Mild injection site reactions that improve with rotation
- Possible flu-like symptoms after first few doses
- Perhaps slightly more fatigue as immune system activates
- Nothing dramatic—changes are happening at the cellular level
What's normal
- Temporary discomfort at injection sites
- Mild muscle aches or fatigue
- Feeling 'off' for a few hours after injection
- Not feeling anything different at all
What's next
- Side effects typically improve after the first week
- Continue your twice-weekly schedule consistently
- Track any effects in a simple journal
Week 3-6
What you might notice
- Injection tolerance improves significantly
- Some people report feeling more resilient to minor bugs
- Energy levels may stabilize or improve
- If fighting infection, viral markers may start improving
What's normal
- Settled into routine with minimal side effects
- Gradual sense of improved resilience
- Lab work showing immune marker changes (if testing)
What's next
- Continue consistent dosing schedule
- This is when clinical benefits typically become measurable
- Consider lab testing if tracking immune function
Week 7-12+
What you might notice
- Established benefits maintained
- Noticeably fewer or shorter illnesses for some users
- Improved lab markers if monitoring
- Overall sense of immune competence
What's normal
- Minimal to no side effects at this stage
- Benefits feel 'normal'—you might only notice when you stop
- Stable immune function markers
What's next
- Discuss with provider whether to continue or cycle off
- Some protocols continue long-term; others take breaks
- Long-term safety data supports extended use when indicated
Signs it's working
General Immune Resilience
- Fewer colds or respiratory infections
- Faster recovery when you do get sick
- Less severe symptoms when exposed to illness
- Improved energy and fewer 'run down' periods
Laboratory Markers (if testing)
- Improved T-cell counts or function
- Normalized liver enzymes (for hepatitis)
- Reduced viral load measurements
- Better NK (natural killer) cell activity
Condition-Specific Improvements
- Hepatitis: Normalized ALT/AST, reduced HBV DNA levels
- Cancer adjunct: Maintained white blood cell counts during chemo
- General: Fewer infections requiring antibiotics
- Faster wound healing and recovery from illness
Not seeing results? Common reasons
- Expecting immediate results—immune modulation takes weeks to months, not days
- Inconsistent dosing—skipping doses or irregular scheduling reduces effectiveness
- Poor quality peptide—always verify third-party testing and proper storage
- Degraded product—check for cloudiness or particles before each use
- Underlying condition too severe—Thymosin Alpha-1 supports but doesn't replace primary treatment
- Unrealistic expectations—it enhances immune function, not replaces it entirely
Key research
Clinical trials
Thymosin Alpha-1 tested in people
46 registered studies, 11 still enrolling.
By phase
A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.
What kind of research
About 9,820 people took part in the studies that actually administered Thymosin Alpha-1. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.
Most recent
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Nanjing Medical University
Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer
The Affiliated Hospital of Putian University
"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"
Beijing Friendship Hospital
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when Thymosin Alpha-1 is named as an intervention; studies that only mention it in passing are not.
Questions
Frequently asked about Thymosin Alpha-1
How is Thymosin Alpha-1 different from Thymosin Beta-4 (TB-500)?
They're from the same thymosin family but do completely different things. Thymosin Alpha-1 focuses on immune function—training and activating immune cells. Thymosin Beta-4 (TB-500) is about tissue repair, wound healing, and reducing inflammation. Think of TA-1 as the immune system coach and TB-4 as the body's repair crew. You can use them together for comprehensive support.
Is Thymosin Alpha-1 FDA approved?
It's complicated. The FDA granted orphan drug status for hepatocellular carcinoma, and the synthetic version (Zadaxin/thymalfasin) is approved for certain uses. However, it's approved and widely used in over 30 other countries including China, Russia, and much of Asia for hepatitis and immune support. In the US, it's often accessed through compounding pharmacies for research purposes.
Can I use Thymosin Alpha-1 if I have an autoimmune condition?
This requires careful medical supervision. While Thymosin Alpha-1 has immunomodulating properties that could theoretically help balance immune function, stimulating immunity in someone with autoimmune disease could also trigger flares. Some research suggests benefits in certain autoimmune scenarios, but this isn't something to try without close medical oversight.
How long does it take to notice benefits?
Most people don't feel dramatic immediate effects—this isn't like taking a stimulant. Immune benefits typically become noticeable over weeks to months: fewer infections, faster recovery when sick, improved lab markers if you're testing. Clinical trials usually run 6-12 months to see meaningful outcomes. Think of it as gradually strengthening your defenses, not flipping a switch.
Why is the dose always 1.6 mg?
This dose (technically 900 mcg/m2 body surface area, which works out to about 1.6 mg for most adults) was established through extensive clinical trials as the sweet spot for effectiveness and safety. Higher doses didn't show better results in studies, and this dose has decades of safety data. It's one of the most studied peptide doses in existence.
Can I take it continuously or do I need to cycle?
Unlike some peptides, Thymosin Alpha-1 has been used continuously for extended periods in clinical settings—some hepatitis trials ran 12+ months. That said, many people do cycle (8-12 weeks on, 4-8 weeks off) for general immune maintenance. Discuss with your provider what makes sense for your specific goals. There's no evidence of tolerance or reduced effectiveness with longer use.
Will it help me not get sick?
Thymosin Alpha-1 enhances your immune system's ability to respond to threats—it doesn't create a magic shield. Users often report fewer infections and faster recovery, but you can still catch viruses and bacteria. Think of it as improving your odds and reducing severity, not providing immunity. It's particularly valuable for people whose immune systems need extra support.
Is this the same as getting thymus extract supplements?
No—those are very different. Oral thymus glandular supplements are crude extracts that mostly get digested before they can do anything. Thymosin Alpha-1 is a specific, pure 28-amino-acid peptide sequence that's injected to bypass digestion and ensure it reaches your immune system intact. The precision and delivery method make a huge difference in effectiveness.
Further reading
Thymosin Alpha-1 history & related research
Ready for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Thymosin Alpha-1, on one page.